Table 2

 Median age and hepatitis B e antigen/antibody to hepatitis B e antigen (HBeAg/anti-HBe) status at the time of development of complications of cirrhosis and hepatocellular carcinoma

Age (y) at the time of complications (median (range))HBeAg/anti-HBe (% anti-HBe +ve)
SBP, spontaneous bacterial peritonitis; HCC, hepatocellular carcinoma.
Ascites (n = 96)57.7 (29–78.1)30/66 (68.8%)
SBP (n = 30)60.0 (32.2–78.0)7/23 (76.7%)
Oesophageal varices (n = 59)54.3 (25.4–82.3)14/45 (76.3%)
Encephalopathy (n = 40)58.5 (27.6–83.1)14/26 (65%)
HCC (n = 95)59 (24.8–82)18/77 (81.1%)
All complications (n = 170)57.2 (24.8–83.1)45/125 (73.5%)